Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc

<< Previous

Bullboard Posts

Next >>

Post by Trogarzonon Mar 20, 2023 5:15pm

235 Views

Post# 35349886

Next Milestone

I guess the consultative comittte will submit their Th1902 recommendation soon. If it's a go to move ahead with a amended protocol I shure hope they don't waste a good opportunity to put it the face of the World that these super people agreed and WHY it's such a great idea. Just in case they do it on a thursday 6:00pm PR after a run on the bank trading day.

<< Previous

Bullboard Posts

Next >>

2024, a breakthrough year for silver